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1. INTRODUCTION {#jcmm14016-sec-0001}
===============

Acute coronary syndrome (ACS) remains a major cause of morbidity and mortality worldwide, in which ischaemic complication represents the leading cause in cardiovascular diseases, such as hypertension and atherosclerosis.[1](#jcmm14016-bib-0001){ref-type="ref"} Angiogenesis is critical for re‐establishing the blood supply to the surviving myocardium after myocardial infarction (MI) and, consequently, to the recovery of cardiac function.[2](#jcmm14016-bib-0002){ref-type="ref"} In response to pro‐angiogenic stimuli, vascular endothelial cells need to be activated rapidly to migrate to distant sites and proliferate to form new primary capillaries from existing ones.[3](#jcmm14016-bib-0003){ref-type="ref"}, [4](#jcmm14016-bib-0004){ref-type="ref"} Impaired angiogenic responses of endothelial cells have been linked to poor cardiac function and outcome after ACS clinically. Therefore, better understandings of the molecular mechanisms of angiogenesis provide a basis for therapeutic application in ACS patients.

MicroRNA is a kind of small, nonprotein‐coding RNA that binds to specific 3′ untranslated regions (3′‐UTR) of mRNA and represses target gene expression through inhibition of translation or transcript degradation.[5](#jcmm14016-bib-0005){ref-type="ref"} In vascular cells, several microRNAs, such as miR‐126, miR‐217, miR‐10a, miR‐124, etc., have been identified to regulate multiple cellular functions including the glucose and lipid metabolisms, senescence and blood flow.[6](#jcmm14016-bib-0006){ref-type="ref"}, [7](#jcmm14016-bib-0007){ref-type="ref"}, [8](#jcmm14016-bib-0008){ref-type="ref"}, [9](#jcmm14016-bib-0009){ref-type="ref"} We have previously reported that miR‐15b‐5p regulates collateral artery formation by targeting protein kinase B in endothelial cells and miR‐199 regulates normalise arachidonic acid metabolism in nitrate tolerance by prostaglandin synthase.[10](#jcmm14016-bib-0010){ref-type="ref"}, [11](#jcmm14016-bib-0011){ref-type="ref"} Interestingly, endogenous expressions of miR‐133a and miR‐130, are null or very low in quiescent endothelial cells, while their expressions are ectopically induced by risk factors, resulting in endothelial dysfunction.[12](#jcmm14016-bib-0012){ref-type="ref"}, [13](#jcmm14016-bib-0013){ref-type="ref"} These results indicate that expressional alterations of endogenous microRNAs are crucial to regulations of endothelial functions. However, the roles of microRNA in hypoxia‐induced angiogenesis in endothelial cells remain poorly understood.

Based on the aforementioned studies, we tested the hypothesis that hypoxia affects endogenous microRNA expressions to promote angiogenesis in ischaemic heart. In this study, we firstly got 18 differentially expressed circulating microRNAs in plasma from ACS patients by using high‐throughput sequencing and then identified the function of miR‐185‐5p as a key regulator of angiogenesis by targeting cathepsin K (CatK), which plays an important role in regulating vascular repair.[14](#jcmm14016-bib-0014){ref-type="ref"} In vivo studies demonstrated that endogenous reduction of miR‐185‐5p was vital to the recovery of heart function after ischaemia in mice with MI. In perspectives, targeting miR‐185‐5p or CatK should be taken into consideration when treating ACS patients.

2. MATERIALS AND METHODS {#jcmm14016-sec-0002}
========================

A full description of materials and methods used, including patient recruitments, high‐throughput RNA sequencing, real‐time reverse transcription PCR (qPCR), induction of MI in mice, agomir infusion to mice, adenovirus infection, fluorescence in situ hybridisation (FISH), echocardiography, masson\'s trichrome staining, immunohistochemistry (IHC), immunofluorescence (IFC), cell cultures, plasmid transfection, luciferase reporter assay, western blot, cell proliferations, cell migrations, tube formation and statistical analysis were available as Supplemental Materials.

2.1. Patient recruitments {#jcmm14016-sec-0003}
-------------------------

Patients who underwent coronary angiography were enrolled from the cardiac catheterisation room of Xiangya Hospital, Central South University, Hunan Province, China during 2014 and 2016. Thirty patients with ACS were selected with previously typical unstable angina pectoris or diagnosed as MI. A significant stenosis was defined as diameter stenosis ≥90% through coronary angiography. The patients were excluded if they had other potentiality that could influence neovascularisation, like symptomatic peripheral arterial diseases, decompensated heart failure, any concomitant inflammation or infectious diseases, neoplastic diseases and severe liver and kidney dysfunctions. Thirty patients who had no angina pectoris and coronary angiography revealed stenosis as diameter stenosis \<50% were chosen as control. We documented all the cardiac history and risk factors. Informed consent was obtained from all participants. The study protocol was approved by the Ethics Committee of Xiangya Hospital, Central South University, Changsha, Hunan, China.

2.2. High‐throughput RNA sequencing {#jcmm14016-sec-0004}
-----------------------------------

As described previously,[15](#jcmm14016-bib-0015){ref-type="ref"}, [16](#jcmm14016-bib-0016){ref-type="ref"} total RNA extracted from plasma was used to prepare the miRNA sequencing library by using an Agilent 2100 Bioanalyzer. Next, cluster generation was performed on the Illumina cBot using the TruSeq Rapid SR cluster kit (\#GD‐402‐4001; Illumina, San Diego, CA, USA). The DNA fragments in the libraries were denatured with 0.1 mol/L NaOH to generate single−stranded DNA molecules. They were then observed on Illumina flow cells, amplified in situ and sequenced for 36 cycles with an Illumina HiSeq 2000 (Illumina), according to the manufacturer\'s instructions.

2.3. Statistical analysis {#jcmm14016-sec-0005}
-------------------------

All quantitative results are expressed as mean ± SEM. Comparisons between two groups were analysed by unpaired Student\'s *t* test. Multiple comparisons were analysed with a one‐way [anova]{.smallcaps} followed by Tukey post‐hoc tests or Bonferroni post‐hoc analyses. Categorical variables were compared by the chi‐squared test. Statistical analysis was conducted using IBM SPSS statistics 20.0 (IBM Corp., Armonk, NY, USA) and *P* \< 0.05 were considered as statistical significance.

3. RESULTS {#jcmm14016-sec-0006}
==========

3.1. Eighteen circulating microRNAs including miR‐185‐5p are differentially expressed in plasma from ACS patients {#jcmm14016-sec-0007}
-----------------------------------------------------------------------------------------------------------------

To identify which microRNAs were dysregulated in patients with ACS, we firstly collected plasma from 10 patients with ACS and five patients without ACS. High‐throughput RNA sequencing was performed to detect the expressional profiles of microRNAs in plasma and we got 18 differentially expressed microRNAs (Figure [1](#jcmm14016-fig-0001){ref-type="fig"}A). Among these altered microRNAs, six microRNAs (hsa‐miR‐221‐3p, hsa‐miR‐382‐5p, hsa‐miR‐17‐5p, hsa‐miR‐1, hsa‐miR‐5187‐5p and hsa‐miR‐1908‐5p) were increased, while 12 microRNAs (hsa‐miR‐148b‐3p, hsa‐miR‐101‐3p, hsa‐miR‐185‐5p, hsa‐miR‐192‐5p, hsa‐miR‐378a‐3p, hsa‐miR‐30b‐5p, hsa‐miR‐425‐5p, hsa‐miR‐23b‐3p, hsa‐miR‐146b‐5p, hsa‐miR‐877‐5p, hsa‐miR‐99b‐5p, hsa‐miR‐125a‐5p, hsa‐miR‐5157‐5p) were decreased.

![The expressional levels of miR‐185‐5p are decreased in plasma from patients with ACS and hearts isolated from mice following MI. (A) Plasma from five human individuals without ACS (number 1‐5) and 10 patients with ACS (number 6‐15) were subjected to perform high‐throughput microRNA sequencing. Eighteen differentially expressed miRNAs with 2‐fold changes or higher were shown in the heat map of hierarchical RNA clustering. (B) The plasma levels of miR‐185‐5p were detected in 30 human individuals without ACS and 30 ACS patients by real‐time RT‐PCR. The demographic data were presented in Table [S1](#jcmm14016-sup-0001){ref-type="supplementary-material"}. \**P* \< 0.05 vs non‐ACS. (C‐E) FISH analysis of miR‐185‐5p in hearts were performed in mice following MI after 7 postoperative days in C. Red, miR‐185‐5p. Green, CD31. Blue, DAPI. Scar bar is 50 μm. Quantitative analyses of miR‐185‐5p levels in D and capillary intensities in E were conducted in data from C. N = 10 per group. \**P* \< 0.05 vs Sham](JCMM-23-1164-g001){#jcmm14016-fig-0001}

Because miR‐185‐5p has been reported to inhibit angiogenesis and response to hypoxia,[17](#jcmm14016-bib-0017){ref-type="ref"}, [18](#jcmm14016-bib-0018){ref-type="ref"} we chose miR‐185‐5p as a candidate to regulate angiogenesis and the recovery of heart function after MI. Therefore, we confirmed the plasma levels of miR‐185‐5p by qPCR in 30 ACS patients (the demographic data were presented in Table [S1](#jcmm14016-sup-0001){ref-type="supplementary-material"}). As indicated in Figure [1](#jcmm14016-fig-0001){ref-type="fig"}B, plasma miR‐185‐5p levels were down‐regulated in patients with ACS, compared to patients without ACS.

3.2. MiR‐185‐5p is reduced in ischaemic heart in mice following MI {#jcmm14016-sec-0008}
------------------------------------------------------------------

To determine whether miR‐185‐5p is vital to ischaemia‐induced angiogenesis in heart, we performed FISH analysis to measure miR‐185‐5p expression in mice heart at 7 post‐MI days. As depicted in Figure [1](#jcmm14016-fig-0001){ref-type="fig"}C, miR‐185‐5p expression was positively expressed in both cardio myocytes and endothelial cells under physiological condition. While, miR‐185‐5p expression in heart was remarkably reduced in ischaemic heart in mice with MI. The reduction of miR‐185‐5p expression in ischaemic heart was further confirmed by qPCR analysis (Figure [1](#jcmm14016-fig-0001){ref-type="fig"}D). Further, decreased miR‐185‐5p expression was associated with increased capillary intensity (Figure [1](#jcmm14016-fig-0001){ref-type="fig"}E), as indicated by quantitative analysis of CD31. These data suggest that miR‐185‐5p reduction may contribute to ischaemia‐induced angiogenesis in heart.

3.3. Hypoxia reduces miR‐185‐5p expression in endothelial cells {#jcmm14016-sec-0009}
---------------------------------------------------------------

As the key cells of endothelial cells in angiogenesis,[19](#jcmm14016-bib-0019){ref-type="ref"} we next examined the effects of ischaemia on miR‐185‐5p expressions in cultured human umbilical vein endothelial cells (HUVECs). Ischaemia was simulated by hypoxia, as confirmed by positive expression of hypoxia inducible factor 1 α in HUVECs (Figure [S1](#jcmm14016-sup-0001){ref-type="supplementary-material"}). In Figure [2](#jcmm14016-fig-0002){ref-type="fig"}A, hypoxia noticeably reduced the levels of miR‐185‐5p in a time‐dependent manner, suggesting that endogenous expression of miR‐185‐5p is suppressed in endothelial cells under hypoxia.

![Cathepsin K (CatK) mRNA is a target of miR‐185‐5p in endothelial cells. (A) Cultured HUVECs were exposed to hypoxic conditions as indicated time and miR‐185‐5p expressional levels were assayed by real‐time RT‐PCR. N = 5 per group. \**P* \< 0.05 vs control (point 0). (B) The highly conserved putative target site of miR‐185‐5p in 3′‐UTR of CatK mRNA was predicted by target scan analysis. (C) Plasmids of luciferase reporter gene construction containing the full‐length wild‐type 3′‐UTR of CatK mRNA (WT‐CatK‐3′‐UTR) and mutated 3′‐UTR of CatK mRNA (MT‐CatK‐3′‐UTR) were generated and transfected into HEK293 cells with control or miR‐185‐5p mimics. The luciferase activity in total cell lysates was assayed. N = 5 per group. \**P* \< 0.05 vs WT‐CatK‐3′‐UTR alone. NS indicates no significance. (D and E) HUVECs were transfected with miR‐185‐5p inhibitors in D or mimics in E for 48 h. Cells were subjected to detect the levels of CatK mRNA by real‐time RT‐PCR. N = 5 per group. \**P* \< 0.05 vs control. (F) HUVECs were transfected with miR‐185‐5p mimics and inhibitors for 48 h. Total cell lysates were subjected to determine the protein levels of CatK by Western blot. a, Control. b, Control mimics. c, miR‐185‐5p mimics. d, Control inhibitors. e, miR‐185‐5p inhibitors. N = 5 per group. \**P* \< 0.05 vs control mimics (b). ^\#^ *P* \< 0.05 vs control inhibitors (d)](JCMM-23-1164-g002){#jcmm14016-fig-0002}

3.4. CatK is a target of miR‐185‐5p in endothelial cells {#jcmm14016-sec-0010}
--------------------------------------------------------

In order to investigate how miR‐185‐5p regulates angiogenesis under hypoxia, we used TargetScan database to predict the potential target of miR‐185‐5p. Computational target scan analysis showed that a highly conserved putative target site of miR‐185‐5p located in 3′‐UTR of CatK mRNA among human, rat and mouse (Figure [2](#jcmm14016-fig-0002){ref-type="fig"}B). To examine whether miR‐185‐5p is able to repress CatK gene expression through direct 3′‐UTR interaction, we cloned wild‐type CatK 3′‐UTR (WT‐CatK‐3′‐UTR) or mutated CatK 3′‐UTR (MT‐CatK‐3′‐UTR) to luciferase reporter plasmid and performed reporter analysis in HEK293 cells. As shown in Figure [2](#jcmm14016-fig-0002){ref-type="fig"}C, the co‐transfection of miR‐185‐5p mimics with plasmid of WT‐CatK‐3′‐UTR reporter gene reduced luciferase activity. However, co‐transfection of miR‐185‐5p mimics with plasmid of MT‐CatK‐3′‐UTR reporter gene did not result in a significant inhibition of luciferase activity. These data indicated that CatK is a target of miR‐185‐5p.

To further verify if CatK is a target gene of miR‐185‐5p in endothelial cells, HUVECs were transfected with miR‐185 inhibitors or miR‐185 mimics. Inhibition of miR‐185‐5p up‐regulated CatK mRNA level (Figure [2](#jcmm14016-fig-0002){ref-type="fig"}D), while miR‐185 mimics down‐regulated CatK mRNA level (Figure [2](#jcmm14016-fig-0002){ref-type="fig"}E). Further, Western blot analysis revealed that suppression of miR‐185‐5p increased CatK protein level, while miR‐185 overexpression did opposite (Figure [2](#jcmm14016-fig-0002){ref-type="fig"}F). These data demonstrate that CatK is a target of miR‐185‐5p in endothelial cells.

3.5. MiR‐185‐5p inhibits cell proliferation and migration in HUVECs under hypoxia {#jcmm14016-sec-0011}
---------------------------------------------------------------------------------

Both proliferation and migration of endothelial cells are essential to the postischaemic angiogenesis.[4](#jcmm14016-bib-0004){ref-type="ref"} Thus, we examined whether miR‐185‐5p reduction contributes to hypoxia‐induced cell proliferation and migration in cultured HUVECs, as determined by CCK‐8 and BrdU assay (Figure [S2](#jcmm14016-sup-0001){ref-type="supplementary-material"}). As presented in Figure [3](#jcmm14016-fig-0003){ref-type="fig"}A, B, gain‐function of miR‐185‐5p by specific mimics decreased cell proliferation; however, loss‐function of miR‐185‐5p by specific inhibitors further enhanced cell proliferations in HUVECs under hypoxia. Similarly, miR‐185‐5p mimics inhibited cell migrations, but miR‐185‐5p inhibitors increased cell migrations in HUVECs under hypoxia (Figure [3](#jcmm14016-fig-0003){ref-type="fig"}C, D). These findings prove that miR‐185‐5p is crucial to cell proliferation and migration during hypoxia.

![MiR‐185‐5p negatively regulates HUVECs proliferations and migrations under hypoxia. Cultured HUVECs were transfected with control mimics, miR‐185‐5p mimics (50 nmol/L), control inhibitors and miR‐185‐5p inhibitors (100 nmol/L) for 48 h followed by 24‐h hypoxia. a, Control. b, Hypoxia. c, Hypoxia plus control mimics. d, Hypoxia plus miR‐185‐5p mimics. e, Hypoxia plus control inhibitors. f, Hypoxia plus miR‐185‐5p inhibitors. (A and B) Cell proliferations were determined by CCK8 in A and BrdU in B. (C‐E) Cell migration and tube formation were assayed in HUVECs after treatments and representative pictures were shown in C. Quantitative analysis of cell migration in D and tube formation in E were performed in data from C. N = 5 per group. \**P* \< 0.05 vs control (a). ^\#^ *P* \< 0.05 vs hypoxia plus control mimics (c). ^&^ *P* \< 0.05 vs hypoxia plus control inhibitors (e)](JCMM-23-1164-g003){#jcmm14016-fig-0003}

3.6. MiR‐185‐5p impairs tube formations in HUVECs under hypoxia {#jcmm14016-sec-0012}
---------------------------------------------------------------

Tube formation is a vital step in endothelial cell‐mediated angiogenesis.[20](#jcmm14016-bib-0020){ref-type="ref"} Therefore, we examined if miR‐185‐5p regulates hypoxia‐induced tube formation in HUVECs. As indicated in Figure [3](#jcmm14016-fig-0003){ref-type="fig"}C, E, miR‐185‐5p up‐regulation by mimics inhibited tube formations, but miR‐185‐5p suppression by inhibitors increased tube formations in HUVECs under hypoxia.

3.7. MiR‐185‐5p delays wound healing in HUVECs under hypoxia {#jcmm14016-sec-0013}
------------------------------------------------------------

We next detected whether miR‐185‐5p regulates angiogenesis by performing wound healing test. The wound healing was determined at 24 and 48 hours after scratch‐induced injury in cultured HUVECs. As demonstrated in Figure [4](#jcmm14016-fig-0004){ref-type="fig"}A‐C, up‐regulation of miR‐185‐5p by mimics delayed wound healing, while miR‐185‐5p inhibitors promoted wound healing in HUVECs under hypoxia. Collectively, these data suggest that miR‐185‐5p regulates angiogenesis including cell proliferation, migration, tube formation and would healing in endothelial cells under hypoxia.

![MiR‐185‐5p suppresses wound healing in cultured HUVECs. (A) Cultured HUVECs were transfected with control mimics, miR‐185‐5p mimics (50 nmol/L), control inhibitors and miR‐185‐5p inhibitors (100 nmol/L) for 48 h followed by 24‐h hypoxia. a, Control. b, Hypoxia. c, Hypoxia plus control mimics. d, Hypoxia plus miR‐185‐5p mimics. e, Hypoxia plus control inhibitors. f, Hypoxia plus miR‐185‐5p inhibitors. Wound healing was assessed in HUVECs at 24 and 48 h after scratching. (B and C) Quantitative analysis of wound healing after 24 h in B or after 24 h in C was conducted in data from A. N = 5 per group. \**P* \< 0.05 vs control (a). ^\#^ *P* \< 0.05 vs hypoxia plus control mimics (c). ^&^ *P* \< 0.05 vs hypoxia plus control inhibitors (e)](JCMM-23-1164-g004){#jcmm14016-fig-0004}

3.8. Overexpression of CatK abolishes the effects of miR‐185‐5p on proliferation, migration and tube formation of HUVECs {#jcmm14016-sec-0014}
------------------------------------------------------------------------------------------------------------------------

To determine whether CatK mediates the effects of miR‐185‐5p on cellular functions, HUVECs infected with adenovirus expressing CatK were transfected with miR‐185‐5p mimic for 24‐48 hours followed by hypoxia. As represented, miR‐185‐5p mimic inhibited cell proliferation (Figure [5](#jcmm14016-fig-0005){ref-type="fig"}A), migration (Figure [5](#jcmm14016-fig-0005){ref-type="fig"}B, C) and tube formation (Figure [5](#jcmm14016-fig-0005){ref-type="fig"}B, D) in cultured HUVECs under hypoxia when cells were infected with adenovirus vector, but it did not produce these inhibitory effects in cells infected with adenovirus expressing CatK mRNA.

![Overexpression of cathepsin K (CatK) abolishes the inhibitory effects of miR‐185‐5p on proliferation, migration and tube formation of HUVECs under hypoxia. Cultured HUVECs were infected with adenovirus expressing CatK for 48 h followed by transfection with controls and miR‐185‐5p mimics (50 nmol/L) for 24 h. Then cells were exposed to hypoxia for 24 h. a, Control mimics. b, Hypoxia plus control mimics. c, Hypoxia plus miR‐185‐5p mimics plus vector. d, Hypoxia plus miR‐185‐5p mimics plus CatK. e, Hypoxia plus control mimics plus CatK. (A) Cell proliferations were determined by CCK8. (B) Cell migration and tube formation were assayed in HUVECs after treatments and representative pictures were shown. (C and D) Quantitative analysis of cell migration in C and tube formation in D were performed in data from B. N = 5 per group. \**P* \< 0.05 vs control mimics (a). ^\#^ *P* \< 0.05 vs hypoxia plus miR‐185‐5p mimics plus vector (c). ^&^ *P* \< 0.05 vs hypoxia plus control mimics plus CatK (e)](JCMM-23-1164-g005){#jcmm14016-fig-0005}

3.9. Silencing CatK ablates the effects of miR‐185‐5p inhibition on cell proliferations, migrations and tube formations in HUVECs {#jcmm14016-sec-0015}
---------------------------------------------------------------------------------------------------------------------------------

Conversely, we detected the effects of miR‐185‐5p inhibitors on cellular functions if CatK is null by infecting HUVECs with adenovirus expressing CatK shRNA. As expected, miR‐185‐5p inhibitor mirrored or enhanced hypoxia‐induced cell proliferations (Figure [S3](#jcmm14016-sup-0001){ref-type="supplementary-material"}A), migrations (Figure [S3](#jcmm14016-sup-0001){ref-type="supplementary-material"}B, C) and tube formations (Figure [S3](#jcmm14016-sup-0001){ref-type="supplementary-material"}B, D) in cultured HUVECs. Importantly, these effects of miR‐185‐5p inhibitors were abolished by CatK shRNA but not scramble shRNA. These data support this notion that CatK acts as the downstream target of miR‐185‐5p in regulating angiogenesis.

3.10. CatK regulates c‐notch1, Hes1, Hey1 and Hey2 mRNA expression in HUVECs {#jcmm14016-sec-0016}
----------------------------------------------------------------------------

To uncover how CatK regulates angiogenesis, we measured notch signalling, which has been reported to play critical roles in vascular development.[21](#jcmm14016-bib-0021){ref-type="ref"}, [22](#jcmm14016-bib-0022){ref-type="ref"} As shown in Figure [S4](#jcmm14016-sup-0001){ref-type="supplementary-material"}A, CatK gene silencing by shRNA reduced c‐notch1 protein level, while CatK overexpression dramatically up‐regulated c‐notch1 protein level in HUVECs under hypoxia. Further, mRNA expressions of Hes1, Hey1 and Hey2, which are the downstream genes of notch,[23](#jcmm14016-bib-0023){ref-type="ref"}, [24](#jcmm14016-bib-0024){ref-type="ref"} were significantly repressed by CatK shRNA (Figure [S4](#jcmm14016-sup-0001){ref-type="supplementary-material"}B), but activated by CatK gene overexpression (Figure [S4](#jcmm14016-sup-0001){ref-type="supplementary-material"}C).

3.11. Gain‐function of miR‐185‐5p inhibits ischaemia‐induced angiogenesis in mice following MI {#jcmm14016-sec-0017}
----------------------------------------------------------------------------------------------

Knowing that miR‐185‐5p negatively regulates proliferations, migrations and tube formations in endothelial cells by targeting CatK, we next determined whether up‐regulation of miR‐185‐5p inhibits angiogenesis in ischaemic heart in vivo. To this point, mice were infused with miR‐185‐5p agomir and were conducted with MI surgery (Figure [S5](#jcmm14016-sup-0001){ref-type="supplementary-material"}A). Infusion of miR‐185‐5p agomir obviously increased miR‐185‐5p levels in hearts, compared with control agomir (Figure [S5](#jcmm14016-sup-0001){ref-type="supplementary-material"}B). As indicated in Figure [6](#jcmm14016-fig-0006){ref-type="fig"}A, B, the capillary intensities in ischaemic area of hearts isolated from mice with MI after 28 postoperative days were significantly higher than hearts from mice with sham surgery, as determined by IHC analysis of CD31. Treatment of miR‐185‐5p agomir but not control agomir completely reduced capillary numbers in mice with MI. Furthermore, administration of miR‐185‐5p agomir reduced fibrosis in ischaemic heart (Figure [6](#jcmm14016-fig-0006){ref-type="fig"}A, C). These results suggest that miR‐185‐5p reduction contributes to ischaemia‐induced angiogenesis in mice after MI.

![Gain‐function of miR‐185‐5p impairs angiogenesis and delays the recovery of cardiac functions in mice following MI. The animal protocols of miR‐185‐5p agomir infusion and MI model induction were shown in Figure [S5A](#jcmm14016-sup-0001){ref-type="supplementary-material"}. (A‐C) IHC analysis of CD31 and masson\'s trichrome staining of fibrosis were performed in cross‐sections of left ventricle in mice after 28 postoperative days. Representative pictures were presented in A. Quantitation of capillary intensities in B or fibrosis in C was conducted. (D‐F) Heart functions were determined by echocardiography in mice after 28 postoperative days before scarified. Representative images of M‐mode echocardiography were shown in D. Both EF in E and FS in F were calculated. N = 10‐15 per group. \**P* \< 0.05 vs Sham. ^\#^ *P* \< 0.05 vs MI plus negative agomir](JCMM-23-1164-g006){#jcmm14016-fig-0006}

3.12. MiR‐185‐5p agomir delays the recovery of heart functions in mice following MI {#jcmm14016-sec-0018}
-----------------------------------------------------------------------------------

Angiogenesis is a key regenerative event to recover the blood supply and to repair cardiac function in ACS patients.[25](#jcmm14016-bib-0025){ref-type="ref"} Next, we determined whether miR‐185‐5p agomir delays the recovery of heart functions in mice following MI by echocardiographic analysis (Figure [6](#jcmm14016-fig-0006){ref-type="fig"}D). Echocardiographic parameters were shown in Table [S2](#jcmm14016-sup-0001){ref-type="supplementary-material"}. Both EF and FS were dramatically decreased in mice with MI, which were further reduced by miR‐185‐5p agomir, compared to mice with negative agomir treatment (Figure [6](#jcmm14016-fig-0006){ref-type="fig"}E, F).

3.13. Gain‐function of miR‐185‐5p reduces CatK protein expression in mice following MI {#jcmm14016-sec-0019}
--------------------------------------------------------------------------------------

We next examined whether miR‐185‐5p represses CatK gene expression in vivo. As shown in Figure [S6](#jcmm14016-sup-0001){ref-type="supplementary-material"}A, B, IFC analysis indicated that the numbers of both CatK^+^ and CD31^+^ cells in ischaemic area were significantly enhanced in heart isolated from mice with MI, compared to mice with sham. Administration of miR‐185‐5p agomir but not negative agomir extensively repressed CatK protein expressions in CD31^+^ cells in mice after 28 postoperative days. These effects were further confirmed by qPCR analysis showing the mRNA expression of CatK in ischaemic area was significantly reduced by miR‐185‐5p agomir in mice with MI surgery (Figure [S6](#jcmm14016-sup-0001){ref-type="supplementary-material"}C).

3.14. Knockdown of CatK impairs angiogenesis and delays the recovery of heart functions in mice following MI {#jcmm14016-sec-0020}
------------------------------------------------------------------------------------------------------------

Above, we have provided evidence to reveal that CatK mRNA is a target of miR‐185‐5p. As a result, we thought that silencing of CatK would mirror the effects of miR‐185‐5p agomir in mice with MI. To test this notion, in vivo loss‐function of CatK was induced by infecting mice with adenovirus expressing CatK shRNA (Figure [S5](#jcmm14016-sup-0001){ref-type="supplementary-material"}C, D). Similar to miR‐185‐5p agomir, CatK gene silencing decreased capillary intensities and increased fibrosis in ischaemic area of hearts isolated from mice with MI after 28 postoperative days, compared to mice infected with adenovirus expressing scramble shRNA (Figure [S7](#jcmm14016-sup-0001){ref-type="supplementary-material"}A‐C, G, H).

We also detected the effects of CatK gene silencing on cardiac function in mice with MI by echocardiography and the echocardiographic parameters were shown in Table [S3](#jcmm14016-sup-0001){ref-type="supplementary-material"}. As expected, knockdown of CatK gene expression reduced EF and FS in mice infected with adenovirus expressing CatK shRNA at 28 postoperative days after MI surgery (Figure [S7](#jcmm14016-sup-0001){ref-type="supplementary-material"}D‐F). Taking these data together, it reveals that miR‐185‐5p/CatK axis plays a key role in angiogenesis and repair of heart function after MI.

3.15. MiR‐185‐5p agonist and CatK inhibition suppress arteriogenesis in ischaemic heart isolated from mice with MI {#jcmm14016-sec-0021}
------------------------------------------------------------------------------------------------------------------

Growth of functional arteries from angiogenesis, which is driven by flow shear stress, is essential for the restoration of blood flow to ischaemic organs.[26](#jcmm14016-bib-0026){ref-type="ref"}, [27](#jcmm14016-bib-0027){ref-type="ref"} Finally, we examined the roles of miR‐185‐5p and CatK in arteriogenesis in mice heart by performing double staining of CD31 and ɑ‐SMA shown in Figure [S8](#jcmm14016-sup-0001){ref-type="supplementary-material"}A, B, either miR‐185‐5p agonist or CatK shRNA noticeably decreased arterial numbers in ischaemic hearts from mice after 28 postoperative days.

4. DISCUSSION {#jcmm14016-sec-0022}
=============

In this study, we have found that 18 circulating microRNAs including miR‐185‐5p were differently expressed in patients with ACS. We also demonstrated that endogenous reduction of miR‐185‐5p expression in endothelial cells during hypoxia up‐regulated CatK gene expression and activated multiple cellular functions such as proliferation, migration and tube formation. In vivo gene manipulations of miR‐185‐5p up‐regulation by agomir or CatK down‐regulation by adenovirus‐mediated RNA interference impaired angiogenesis and delayed the recovery of cardiac function in mice with MI. To the best of our knowledge, this study is firstly to report that the miR‐185‐5p/CatK axis plays a key role in revascularisation after MI.

The major discovery of the present study is that CatK is a target of miR‐185‐5p in endothelial cells. MiR‐185, located in the 22q11.2 gene locus, is generally regarded as a regulator involved in the biological processes of carcinoma cells and neurological disorders by targeting marginal zone B and B1 cell‐specific protein, etc.[28](#jcmm14016-bib-0028){ref-type="ref"} Several studies have explored the role of CatK in different models of heart failure induced by high‐fat diet, pressure overload, ageing and diabetes.[29](#jcmm14016-bib-0029){ref-type="ref"}, [30](#jcmm14016-bib-0030){ref-type="ref"}, [31](#jcmm14016-bib-0031){ref-type="ref"}, [32](#jcmm14016-bib-0032){ref-type="ref"} However, the potential mechanisms by which CatK regulates the cardiac function after MI remains unknown. Here, we exploited that CatK is a novel target of miR‐185‐5p in endothelial cells. This was demonstrated by the following evidence: (a) miR‐185‐5p target site, which belongs to conserved groups, located in the 3′‐UTR of CatK mRNA as indicated "ACUXXXXXUCUCUCC"; (b) Transfection of miR‐185‐5p decreased luciferase reporter activity in plasmid of WT‐CatK‐3′‐UTR, but not in plasmid of CatK‐3′‐UTR with the mutant of miR‐185‐5p target site; (c) Overexpression of miR‐185‐5p decreased CatK mRNA level, while inhibition of miR‐185‐5p increased CatK gene expression in HUVECs; (d) Importantly, the actions of miR‐185‐5p agomir were compromised by CatK gene overexpression in endothelial cells and were mirrored by CatK gene silencing in mice with MI.

Besides regulating angiogenesis, CatK, as a member of the lysosomal cysteine and aspartic proteinase family, has been shown to be one of the most potent mammalian collagenases. It plays a vital role in maintaining the homeostasis of extracellular matrix.[33](#jcmm14016-bib-0033){ref-type="ref"} Pharmacological inhibition of CatK is a promising novel approach for postmenopausal osteoporosis therapy.[34](#jcmm14016-bib-0034){ref-type="ref"} Overexpression of CatK in mice decreases collagen deposition and lung resistance in response to bleomycin‐induced pulmonary fibrosis.[35](#jcmm14016-bib-0035){ref-type="ref"} We further reported that CatK has some effects on the metabolism of collagen in the late stage of MI. This might be the reason why CatK is mediating a protective effect in cardiac function.

Previous studies have reported that miR‐185 plays important roles in regulation of cell proliferation and apoptosis in response to stress such as oscillating glucose.[36](#jcmm14016-bib-0036){ref-type="ref"} As a tumour suppressive gene, miR‐185 is a pivotal mediator in the cellular response to hypoxia, a state that directly affects angiogenesis.[37](#jcmm14016-bib-0037){ref-type="ref"} In this study, we further uncovered the potential functions of miR‐185 as a suppressor of angiogenesis in revascularisation in ischaemic heart by regulating CatK gene expression. Moreover, the miR‐185‐5p/CatK axis is a key mechanism contributing to the recovery of cardiac function after MI.

We demonstrated that miR‐185‐5p was a key regulation of revascularisation in heart after ischaemia, and may act as a potential therapeutic target in patients with ACS. As an endothelial rich microRNA, miR‐185‐5p is positive in blood and circulating miR‐185 has been reported as a biomarker for clinical outcome in patients with dilated cardiomyopathy.[38](#jcmm14016-bib-0038){ref-type="ref"} By using high‐throughput RNA sequencing, we found 18 microRNAs including miR‐185‐5p in blood were differentially expressed in ACS patient. The reduction of circulating miR‐185‐5p in patients with ACS was further confirmed by quantitative PCR. In vivo experiments also indicate that infusion of miR‐185‐5p agomir delayed the recovery of heart function after MI. Combining the results, we thought that low level of miR‐185‐5p in blood may be associated with the good prognosis of ACS. Consistent with this notion, it has reported that circulating CatK, as a target of miR‐185‐5p identified by us, is a potential novel biomarker of coronary artery disease.[39](#jcmm14016-bib-0039){ref-type="ref"} How miR‐185‐5p is down‐regulated in endothelial cells by hypoxia and reduced in blood in ACS patient needs further investigation.

In summary, we identified that circulating miR‐185‐5p is substantially reduced in ACS patients. Endogenous inhibition of miR‐185‐5p in endothelial cells promotes angiogenesis and accelerates the repair of heart function after MI through targeting CatK gene expression (Figure [S6](#jcmm14016-sup-0001){ref-type="supplementary-material"}D). Therefore, modulation of CatK gene expression by miR‐185‐5p could be effective for an angiogenic therapy in treating ischaemic diseases, including MI, stroke, peripheral artery disease and wound healing in diabetes.[40](#jcmm14016-bib-0040){ref-type="ref"}
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